Hossam Abdel Ghaffar, a spokesman for the Ministry of Health and Population, revealed details of the effectiveness of the new drugs that will arrive in Egypt at the end of January to treat cases of infection with the Corona virus, stressing that they are 3 drugs, the first is “Paxlovid” produced by Pfizer, the second is “molnopiravir” produced by Merck and the third is “Evoshield”.
Hossam Abdel Ghaffar, a spokesman for the Ministry of Health and Population, said in statements to “The Seventh Day” that “Paxlovid” is an antiviral drug that consists of two types, the first type is an inhibitor of virus activity, and the second is a type that maintains the level of concentration of the virus-inhibiting drug in the blood. Oral route and is used in the first days of infection with corona, pointing out that it has emergency use approval from the American and European Medicines Authority.
A spokesman for the Ministry of Health and Population added: Egypt has ended the contract with Pfizer to obtain sufficient doses to treat 20,000 people initially, in the coming weeks.
A spokesman for the Ministry of Health and Population explained that the drug “Molnopiravir” is taken orally and has approval for emergency use from the American and European Medicines Authority. By injection, Egypt contracted to supply enough doses to treat 50,000 people.
.
